logo
Email For Us
Retatrutide
<
>
Retatrutide
Retatrutide
Retatrutide

Retatrutide

Peptides

Description

Basic Info.

Retatrutide is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist.

In a phase II clinical trial, the drug has been proved to reduce the average weight of non diabetes but obese or pre obese (overweight) adults by more than 17.5%


“Strength builds the foundation, and excellent services reach all over the world.”

We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.




GET A QUOTE

Whether you have any questions about our products, please feel free to contact us, we will reply as soon as possible.
Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.

GET IN TOUCH!

© Shenzhen Yuanyang Biotechnology Co., LTD All Rights Reserved.